working at Omnicare
new Defendant Manufacturer/Omnicare illegal PAL solicitation/switching schemes, the
antipsychotics, including Haldol, an inexpensive antipsychotic, as well as Zyprexa and Seroquel,
with Janssen's "preferred" Risperdal, a dramatically more expensive medication than Haldol for
payors. However, the Jacobs pharmacists balked because of the inherent difficulty of converting
dosages of drugs within this therapeutic class to functionally equivalent dosages of Risperdal.
this problem and a Market Share Agreement between Janssen and Omnicare was implemented at
other Omnicare facilities nationwide whereby all prescriptions written for atypical antipsychotics
were switched to Risperdal.
pharmacists and physicians in Omnicare-serviced nursing homes to "educate" these audiences on
the importance of the switching program and on how to switch patients from other atypical
antipsychotics to Risperdal.
and during the attempted mass switching to Risperdal to educate pharmacists on how to make the
switches. Meetings were held with Omnicare staff where Janssen's marketing staff infomled
Omnicare's front line pharmacists and pharmacy supervisors that the switches were not only
going to be beneficial to patients in Omnicare-serviced long-term care facilities, but would save
Janssen also made marketing agents available to Omnicare pharmacists who